Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 9,608 | 11,587 | 10,152 | 10,139 | 7,108 |
| Cost of Goods | 1,120 | 1,063 | 1,226 | 944 | 785 |
| Gross Profit | 8,487 | 10,525 | 8,926 | 9,195 | 6,324 |
| Operating Expenses | 17,347 | 14,746 | 14,107 | 12,582 | 11,525 |
| Operating Income | -8,739 | -4,159 | -4,955 | -2,443 | -4,417 |
| Interest Expense | 0 | 0 | 0 | 289 | 13 |
| Other Income | 479 | 92 | 81 | 52 | 9 |
| Pre-tax Income | -8,260 | -4,067 | -4,874 | -2,680 | -4,422 |
| Net Income Continuous | -8,260 | -4,067 | -4,874 | -2,680 | -4,422 |
| Net Income | $-8,260 | $-4,067 | $-4,874 | $-2,680 | $-4,422 |
| EPS Basic Total Ops | -0.08 | -0.04 | -0.04 | -0.03 | -0.05 |
| EPS Basic Continuous Ops | -0.08 | -0.04 | -0.04 | -0.03 | -0.05 |
| EPS Diluted Total Ops | -0.08 | -0.04 | -0.04 | -0.03 | -0.05 |
| EPS Diluted Continuous Ops | -0.08 | -0.04 | -0.04 | -0.03 | -0.05 |
| EBITDA(a) | $-8,364 | $-3,705 | $-4,570 | $-2,118 | $-4,097 |